A New Paradigm in Oncological Surgery
At Quenet Torrent Institute, we have developed an integrated therapeutic strategy that combines the best of surgical expertise, locoregional chemotherapy and personalised oncological care. This approach represents a departure from one-size-fits-all treatment protocols towards truly individualised oncological management.
Core Elements of Our Strategy
Expert surgical oncology: Cytoreductive surgery, HIPEC/PIPAC, hepatobiliary resections, sarcoma surgery and robotic surgery performed by subspecialty experts with international training. Locoregional chemotherapy: HIPEC and PIPAC deliver chemotherapy directly to the site of disease at concentrations impossible with systemic administration, minimising systemic side effects. Multidisciplinary decision-making: All cases are reviewed by a team including surgical oncologists, medical oncologists, radiologists and pathologists. International second opinions: Patients from around the world bring their cases for independent expert review. Research integration: Participation in clinical trials ensures access to the most innovative treatments.
Who Benefits
Patients with peritoneal carcinomatosis from colorectal, ovarian, gastric, appendiceal or primary peritoneal origin. Patients with liver metastases requiring complex hepatic surgery. Patients with sarcomas of the abdomen, retroperitoneum or extremities. Patients seeking second opinions for difficult or rare oncological diagnoses. Patients who have been told their disease is inoperable at other centres.
Would you like to know if our approach applies to your case? Request a consultation at Quenet Torrent Institute — we review cases from patients worldwide.